Chembio Diagnostics Malaysia Sdn Bhd
Chembio Diagnostics, Inc. develops, manufactures, licenses, and markets rapid diagnostic tests in the growing $8.0 billion POC testing market. Chembio‘s patented DPP® technology platform offers significant advantages over traditional POC lateral-flow technologies and provides the Company with a robust pipeline of business opportunities in the areas of sexually transmitted disease, tropical and fever disease, and technology collaborations.
Muhammad Asyraf
Onn
Research Associate
No. 2-1, 2nd Floor, N-TATT Building
Jalan TP5, Taman Perindustrian UEP
Subang Jaya Selangor 47600
MalaysiaPhone:
60
176400435
E-Mail Address: